Abstract
Acute pulmonary hypertension is frequently observed in patients with acute respiratory distress syndrome (ARDS) and is caused by vasoconstriction and anatomical remodeling of pulmonary vessels [1]. Vasoconstriction of pulmonary vessels appears related to hypoxic pulmonary vasoconstriction, circulating mediators like thromboxane A2 and endothelial-released vasoconstrictors like platelet activating factor (PAF) and endothelin. Constriction of pulmonary vessels is likely non-homogeneously distributed because the pulmonary endothelium may also release vasodilator substances like prostacyclin and nitric oxide (NO) which counteract pulmonary vasoconstriction. The lack of constriction in the non-ventilated parts of the lung results in an increased local blood flow which tends to increase pulmonary shunt leading to life-threatening hypoxemia. Anatomical remodeling of pulmonary vessels is made of muscular hypertrophy, microthrombosis, fibrosis and destruction of pulmonary vessels [2, 3]. The pulmonary vasoconstriction can be reversed by vasodilators whereas pulmonary vasodilation will be reversed by vasoconstrictors.
Keywords
- Nitric Oxide
- Acute Respiratory Failure
- Pulmonary Blood Flow
- Adult Respiratory Distress Syndrome
- Acute Respiratory Distress Syndrome Patient
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Jones R, Langleben D, Reid LM (1991) Patterns and mechanisms of remodeling of the pulmonary circulation in acute and subacute lung injury. In: Said SI (ed) The pulmonary circulation and acute lung injury. Futura Publishing Company, Mount Kisko, NY; pp 179–242
Leeman M (1991) The pulmonary circulation in acute lung injury: A review of some recent advances. Intensive Care Med 17: 254–260
Said SI (1991) The pulmonary circulation and acute lung injury. Futura publishing company, Mount Kisko, NY
Sandiford P, Province MA, Schuster DP (1995) Distribution of regional density and vascular permeability in the adult respiratory distress syndrome. Am J Respir Crit Care Med 151: 737–742
Higenbottam T, Pepke-Zaba J, Scott J, Woolman P, Coutts C, Wallwork J (1988) Inhaled “endothelial derived-relaxing factor” (EDRF) in primary hypertension (PPH). Am Rev Respir Dis (Suppl) 137:A107 (Abst)
Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J (1991) Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 338: 1173–1174
Fratacci MD, Frostell CG, Chen TY, Wain JC, Robinson DR, Zapol WM (1991) Inhaled nitric oxide: A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 75: 990–999
Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM (1991) Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83: 2038–2047
Pison U, Lopez FA, Heidelmeyer CF, Rossaint R, Falke K (1993) Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. J Appl Physiol 74: 1287–1292
Roberts JD, Polaner DM, Lang P, Zapol WM (1992) Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 818–819
Freden F, Wei SZ, Berglund JE, Frostell C, Hedenstrierna G (1995) Nitric oxide modulation of pulmonary blood flow distribution in lobar hypoxia. Anesthesiology 82: 1216–1225
Weitzberg E, Rudehill A, Alving K, Lundberg JM (1991) Nitric oxide inhalation selectively attenuates pulmonary hypertension and arterial hypoxia in porcine endotoxin shock. Acta Physiol Scand 143: 451–452
Berger JI, Gibson RL, Redding GJ, Standaert TA, Clarke WR, Truog WE (1993) Effect of inhaled nitric oxide during group B streptococcal sepsis in piglets. Am Rev Respir Dis 147: 1080–1086
Dyar O, Young JD, Xiong L, John S (1993) Dose-response relationship for inhaled nitric oxide in experimental pulmonary hypertension in sheep. Br J Anaesth 71: 702–708
Dahm P, Blomquist S, Martensson L, Thoine J, Zoucas E (1994) Circulatory and ventilator effects of intermittent nitric oxide inhalation during porcine endotoxemia. J Trauma 37: 769–777
Kavanach BP, Mouchawar A, Goldsmith J, Pearl RG (1994) Effects of inhaled NO and inhibition of endogenous NO synthesis in oxidant-induced acute lung injury. J Appl Physiol 76: 1324–1329
Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328: 399–405
Bigatello LM, Hurford WE, Kacmarek RM, Roberts JD, Zapol WM (1994) Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Anesthesiology 80: 761–770
Puybasset L, Stewart TE, Rouby JJ, et al (1994) Inhaled nitric oxide reverses the increase in pulmonary vascular resistance induced by permissive hypercapnia in patients with ARDS. Anesthesiology 80: 1254–1267
Puybasset L, Rouby JJ, Mourgeon E, et al (1994) Inhaled nitric oxide in acute respiratory failure: Dose-response curves. Intensive Care Med 20: 319–327
Young JD, Brampton WJ, Knighton JD, Finfer SR (1994) Inhaled nitric oxide in acute respiratory failure in adults. Br J Anaesth 73: 499–502
Stenqvist O, Kjelltoft B, Lundin S (1993) Evaluation of a new system for ventilator administration of nitric oxide. Acta Anaesthesiol Scand 37: 687–691
Wessel DL, Adatia I, Thompson JE, Hickey PR (1994) Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit Care Med 22: 930–938
Nishimura M, Hess D, Kacmarek RM, Ritz R, Hurford WE (1995) Nitrogen dioxide production during mechanical ventilation with nitric oxide in adults. Anesthesiology 82: 1246–1254
Moutafis M, Hatahet Z, Castelain MH, Renaudin MH, Monnot A, Fischler M (1995) Validation of a simple method assessing nitric oxide and nitrogen dioxide concentrations. Intensive Care Med 21: 537–541
Lu Q, Mourgeon E, Law-Koune JD, et al (1995) Dose-response of inhaled NO with and without intravenous almitrine in adult respiratory distress syndrome. Anesthesiology 83
Bauer MA, Utell MJ, Morrow PE, Speers DM, Gibb FR (1986) Inhalation of 0.30 ppm nitrogen dioxide potentiates exercice-induced bronchospasm in asthmatics. Am Rev Respir Dis 134: 1203–1208
Hazucha MJ, Founsbee LJ, Sead E, Bromberg PA (1994) Lung function response of healthy women after sequential exposures to NO2 and O3. Am J Respir Crit Care Med 150: 642–647
Sandstrom T, Stjernberg N, Eklund A, et al (1991) Inflammatory cell response in bronchoalveolar lavage fluid after nitrogen dioxide exposure of healthy subjects: A doseresponse study. Eur Respir J 3: 332–339
Law-Koune JD, Rouby JJ, Lu Q, et al (1995) Measurement of inspiratory and expiratory concentration of inhaled NO in patients with ARDS. Br J Anaesth 74 (Suppl 1): A404 (Abst)
Wennmaln A, Benthin G, Edlund A, et al (1993) Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res 73: 1121–1127
Young JD, Dyar O, Xiong L, Howell S (1994) Methemoglobin production in normal adults inhaling low concentrations of nitric oxide. Intensive Care Med 20: 581–584
Isomura K, Chikahira M, Terashini K, Hamada K (1984) Induction of mutations and chromosome aberrations in lung cells following in vivo exposures to nitrogen oxides. Mutation Research 136: 119–125
Arroyo PL, Hatch-Pigott V, Mower HF, Cooney RV (1992) Mutagenecity of nitric oxide and its inhibition by antioxidants. Mutation Research 281: 193–202
Nguyen T, Brunson D, Crospi CL, Penman BW, Wishnok JS, Tannenbaum SR (1992) DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci 89: 3030–3034
Wink DA, Kasprzak KS, Maragos CM, et al (1991) DNA de aminating ability and genotoxicity of nitric oxide and its progenitors. Science 254: 1001–1003
Beckman JS, Beckman TW, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci 87: 1620–1624
Haddad LY, Crow JP, Yaozu Y, Beckman J, Matalon S (1994) Concurrent generation of nitric oxide and superoxide damages surfactant protein A (SP-A). Am J Respir Crit Care Med (Suppl) 149: A549 (Abst)
Greenbaum R, Bay J, Hargreaves MD, et al (1967) Effects of higher oxides of nitrogen in the anaesthetized dog. Br J Anaesth 39: 393–404
Oda H, Nogami H, Kusumotos S, Nakajima T, Kurata A, Imai K (1976) Long-term exposure to nitric oxide in mice. J Jpn Soc Air Pollut 11: 150–160
Oda H, Nogami H, Kusumoto S, Nakajima T, Kurata A (1980) Lifetime exposure to 2.4 ppm nitric oxide in mice. Env Research 22: 254–263
Foubert L, Fleming B, Latimer R, et al (1992) Safety guidelines for use of nitric oxide. Lancet 339: 1615–1616
Man SFP, Williams DJ, Amy GC, Man GCW, Lien DC (1990) Sequential changes in canine pulmonary epithelial and endothelial cell functions after nitrogen dioxide. Am Rev Respir Dis 142: 199–205
Ranga V, Kleinerman J, Ip MPC, Collins AM (1980) The effect of nitrogen dioxide on tracheal uptake and transport of horseradish peroxidase in the guinea pig. Am Rev Respir Dis 122: 483–490
Guth DJ, Mavis RD (1985) Biochemical assessment of acute nitrogen dioxide toxicity in rat lung. Toxicol Appl Pharmacol 81: 128–138
Stavert DM, Lehnert BE (1990) Nitrogen oxide and nitrogen dioxide as inducers of acute pulmonary injury when inhaled at relatively highs concentrations for brief periods. Inhal Toxicol 2: 53–57
Ben-Jebria A, Marthan R, Savineau JP (1992) Effect of in vitro nitrogen dioxide exposure on human bronchial smooth muscle response. Am Rev Respir Dis 146: 378–382
Frampton MW, Morrow PE, Cox C, Gibb FR, Speers DM, Utell MJ (1991) Effects of nitrogen dioxide exposure on pulmonary function and airway reactivity in normal humans. Am Rev Respir Dis 143: 522–527
Stamler JS, Loh E, Roddy MA, Currie KE, Creager MA (1994) Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 89: 2035–2040
Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM (1993) Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 78: 427–435
Puybasset L, Rouby JJ, Mourgeon E, et al (1995) Inhaled NO in acute respiratory failure: Factors influencing pulmonary vascular effects and arterial oxygenation. Am J Respir Crit Care Med 152: 318–328
Gattinoni L, Pesenti A, Avalli L, Rossi F, Bombino M (1987) Pressure-volume curve of total respiratory system in acute respiratory failure. Computed tomographic scan study. Am Rev Respir Dis 136: 730–736
Loh E, Stamler JS, Hare JM, Loscalzo J, Colucci WS (1994) Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation 90: 2780–2785
Bocchi EA, Bacal F, Costa Auter JO, De Carvalho C, Bellotti G, Pileggi F (1994) Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure. Am J Cardiol 74: 70–72
Kieler-Jensen N, Ricksten SE, Stenqvist O, et al (1994) Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. J Heart Lung Transplant 13: 366–375.
Semigran RCS, Cockrill BA, Kacmarek R, et al (1994) Hemodynamic effects of inhaled nitric oxide in patients with left ventricular dysfunction. J Am Coll Cardiol 24: 982–988
Koizumi T, Gupta R, Banerjee M, Newman JH (1994) Changes in pulmonary vascular tone during exercise. Effects of nitric oxide synthase inhibition, L-arginine infusion and NO inhalation. J Clin Invest 94: 2275–2282
Lindeborg DM, Kavanagh BP, Van Meurs K, Pearl RG (1995) Inhaled nitric oxide does not alter the longitudinal distribution of pulmonary vascular resistance. J Appl Physiol 78: 341–348
Benzing A, Geiger K (1994) Inhaled nitric oxide lowers pulmonary capillary pressure and changes longitudinal distribution of pulmonary vascular resistance in patients with acute lung injury. Acta Anaesthesiol Scand 38: 640–645
Scott-Burden T, Vanhoutte PM (1993) The endothelium as a regulator of vascular smooth proliferation. Circulation 87 (Suppl V):V51-V55
Roberts JD, Roberts CT, Jones RC, Zapol WM, Bloch KD (1995) Continuous nitric oxide inhalation reduces pulmonary structural changes, right ventricular hypertrophy and growth retardation in the hypoxic newborn rat. Circ Res 76: 215–222
Radermacher P, Santak B, Becker H, Falke KJ (1989) Prostaglandine E1 and nitroglycerin reduce pulmonary capillary pressure but worsen ventilation-perfusion distributions in patients with adult respiratory distress syndrome. Anesthesiology 70: 601–606
Radermacher P, Santak B, Wiist HJ, Tarnow J, Falke KJ (1990) Prostacyclin for the treatment of pulmonary hypertension in patients with acute respiratory distress syndrome: Effects on pulmonary capillary pressure and ventilation-perfusion distributions. Anesthesiology 72: 238–244
Putensen C, Rasanen J, Lopez FA, Downs JB (1994) Continuous positive airway pressure modulates effect of inhaled nitric oxide on the ventilation-perfusion distribution in canine lung injury. Chest 106: 1563–1569
Fellahi JL, Mourgeon E, Goarin JP, et al (1995) Inhaled nitric oxide-induced closure of a patient foramen ovale in a patient with adult respiratory distress syndrome and lifethreatening hypoxemia. Anesthesiology 83: 635–638
Hagen PT, Scholz DG, Edwards WD (1984) Incidence and size of patent foramen ovale during first decades of life: An autopsy study of 965 normal hearts. Mayo Clin Proc 59: 17–20
Estagnasie P, Le Bourdeles G, Mier L, Coste F, Dreyfuss D (1994) Use of inhaled nitric oxide to reverse flow through a patent foramen ovale during pulmonary embolism. Ann Intern Med 120: 757–759
Stewart TE, Rouby JJ, Puybasset L, Mourgeon E, Descouls AM, Viars P (1994) Inhaled NO reduces alveolar dead space in patients with ARDS and pulmonary hypertension. Am J Respir Crit Care Med (Suppl) 149:A424 (Abst)
Dupuy PM, Shore SA, Drazen JM, Frostell C, Hill WA, Zapol WM (1992) Bronchodilator action of inhaled nitric oxyde in guinea pigs. J Clin Invest 90: 421–428
Hogman M, Frostell CG, Arnberg H, Hedenstierna G (1993) Inhalation of nitric oxide modulates metacholine-induced bronchoconstriction in the rabbit. Eur Respir J 6: 177–180
Puybasset L, Mourgeon E, Segal E, Bodin L, Rouby JJ, Viars P (1993) Effects of inhaled nitric oxide on respiratory resistance in patients with ARDS. Anesthesiology 79 (Suppl 3A): A299 (Abst)
Law-Koune JD, Roche S, Mourgeon E, et al (1994) Acute toxicity of inhaled NO in ARDS. Anesthesiolog 81 (Suppl 3A):A263 (Abst)
Hogman M, Frostell CG, Hedenstrom H, Hedenstierna G (1993) Inhalation of nitric oxide modulates adult bronchial tone. Am Rev Respir Dis 148: 1474–1478
Heffner JE, Sahn SA, Repine JE (1987) The role of platelets in the adult respiratory distress syndrome. Culprits or bystander? Am J Respir Crit Care Med 135: 482–492
Zapol WM, Snider MT, Rie MA, Quinn DA, Frikker M (1985) Pulmonary circulation during adult respiratory distress syndrome. In: Zapol WM, Falke KJ (ed) Acute respiratory failure. Dekker: New York, pp 209–226
Radomski MW, Moncada S (1993) Regulation of vascular homeostasis by nitric oxide. Thromb Haemost 70: 36–41
Loscalzo J (1992) Antiplatelet and antithrombotic effect of organic nitrates. Am J Cardiol 70: 18B-22B
Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ (1981) Evidence for the inhibitory role of guanosine 3’ -5’ monophosphate in ADP induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57: 946–955
Salvemini D, Radziszewski W, Korbut R, Vane J (1990) The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NOdonors. Br J Pharmacol 101: 991–995
Furchgott RF (1988) Studies on relaxation of rabbit aorta by sodium nitrite: The basis for the proposal that acid-activatable inhibitory factor from bovine retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In: Vanhoutte PM (ed) Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium. Raven Press: New York, pp 401–414
Samama CM, Diaby M, Fellahi JL, et al (1995) Inhibition of platelet aggregation by inhaled nitric oxide in patients with adult respiratory distress syndrome. Anesthesiology 83: 56–65
Hogman M, Frostell CG, Arnberg H, Sandhagen B, Hedenstierna G (1994) Prolonged bleeding time during NO inhalation in the rabbit. Acta Physiol Scand 151: 125–129
Hogman M, Frostell CG, Arnberg H, Hedenstierna G (1993) Bleeding time prolongation and NO inhalation. Lancet 341: 1664–1665
Rodgers C, Levin J (1990) A critical reappraisal of the bleeding time. Semin Thromb Hemost 16: 1–20
Golino P, Capelli-Bigazzi E, Ambrosio G, et al (1992) Endothelium-derived relaxing factor modulates platelet aggregation in an in vivo model of recurrent platelet activation. Circ Res 71: 1447–1456
Yao SK, Ober JC, Krishnaswami A, et al (1992) Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endotheliuminjured arteries. Circulation 86: 1302–1309
Folts JD (1991) An in vivo model of experimental arterial stenosis, intimal damage, and periodic thrombosis. Circulation 83:(Suppl IV) 4–14
Garg UC, Hassid A (1989) Nitric oxide-generating vasodilators and 8-bromo cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774–1777
Rimar S, Gillis CN (1992) Pulmonary vasodilation by inhaled nitric oxide after endothelial injury. J Appl Physiol 73: 2179–2183
White CW, Nguyen DH, Tuder R (1994) Nitric oxide modulation of hyperoxic injury. Am J Respir Crit Care Med (Suppl) 149: A548 (Abst)
Berisha H, Pakbaz H, Absood A, Said SI (1994) Excess nitric oxide (NO) production in acute lung injury: Role of constitutive vs inducible NO synthase. Am J Respir Crit Care Med 149:A552 (Abst)
Rovira I, Chen TY, Winkler M, Kawai N, Bloch KD, Zapol WM (1994) Effects of inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of ARDS. J Appl Physiol 76: 345–355
Rich FR, Roos CM, Anderson SM, Urich DC, Daugherty MO, Johns RA (1993) Inhaled nitric oxide: Dose response and the effects of blood in the isolated rat lung. J Appl Physiol 75: 1278–1284
Lowson S, Morris G, Jaidev J, Rich G (1995) Low concentrations of inhaled nitric oxide (NO) in patients with the acute respiratory distress syndrome (ARDS). Anesthesiology 83 (Suppl 3A): A207 (Abst)
Gerlach H, Rossaint R, Pappert D, Falke KJ (1993) Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 23: 499–502
Mourgeon E, Law-koune JD, Lu Q, et al (1995) Inhaled NO in ARDS with and without septic shock: Dose-response curves. Br J Anaesth 74 (Suppl 1):A411 (Abst)
Gerlach H, Pappert D, Lewandowski K, Rossaint R, Falke KJ (1993) Long-term inhalation with evaluated low doses of nitric oxide for selective improvement in oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med 19: 443–449
Journois D, Pouard P, Mauriat P, Malhere T, Vouhe P, Safran D (1994) Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital defects. J Thorac Cardiovasc Surg 107: 1129–1135
Sellden H, Winberg P, Gustafsson LE, Lundell BO, Book K, Frostell CG (1993) Inhalation of nitric oxide reduced pulmonary hypertension after cardiac surgery in a 3.2 kg infant. Anesthesiology 78: 577–580
Tiner NN, Etches RC, Kamstra B, Tierney AJ, Peliowski A, Ryan A (1994) Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: Dose-response. J Pediatr 124: 302–308
Pappert D, Busch T, Gerlach H, Lewandowski K, Radermacher P, Rossaint R (1995) Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome. Anesthesiology 82: 1507–1511
Walmrath D, Schneider T, Pilch J, Grimminger F, Seeger W (1993) Aerosolized prostacyclin reduces pulmonary artery pressure and improves gas exchange in adult respiratory distress syndrome. Lancet 342: 961–962
Walmrath D, Schneider T, Pilch J, Schermuly R, Grimminger F, Seeger W (1995) Effects of aerosolized prostacyclin in severe pneumonia - Impact of fibrosis. Am J Respir Crit Care Med 151: 724–730
Zwissler B, Rank N, Jaenicke U, et al (1995) Selective pulmonary vasodilation by inhaled prostacyclin in a newborn with congenital heart disease and cardiopulmonary bypass. Anesthesiology 82: 1512–1516
Kerins DM, Murray R, Fitzgerald GA (1991) Prostacyclin and prostaglandin E1: Molecular mechanisms and therapeutic utility. Prog Hemostasis Thrombosis 10: 307–337
Parsargiklian M, Bianco S (1980) Ventilatory and cardiovascular effects of prostacyclin and 6-oxo-PGF2cx by inhalation. Adv Prostaglandin Thromboxane Res 7: 943–951
Reyes A, Roca J, Rodriguez-Roisin R, Torres A, Ussetti P, Wagner PD (1988) Effect of almitrine on ventilation-perfusion distribution in adult respiratory distress syndrome. Am Rev Respir Dis 137: 1062–1067
Naeije R, Melot C, Moes P (1981) Effects of almitrine in decompensated chronic respiratory insufficiency. Bull Eur Physiopath Respir 17: 153–161
Dreyfuss D, Djedaini K, Lanore JJ, Mier L, Froidevaux R, Coste F (1992) A comparative study of the effects of almitrine bismesylate and lateral position during unilateral bacterial pneumonia with severe hypoxemia. Am Rev Respir Dis 146: 295–299
Leeman M, Delcroix M, Vachiery JL, Melot C, Naeije R (1992) Almitrine and doxapram in experimental lung injury. Am Rev Respir Dis 145: 1042–1046
Chen L, Miller FL, Malmkvist G, Clergue F, Marschall C, Marschall BE (1987) Highdose almitrine bismesylate inhibits hypoxic pulmonary vasoconstriction in closed chest dogs. Anesthesiology 67: 534–542
Naeije R, Lejeune P, Vachiery JL, et al (1990) Restored hypoxic pulmonary vasoconstriction by peripheral chemoreceptor agonists in dogs. Am Rev Respir Dis 142: 789–795
Gottshall EB, Fernyak S, Wuertemberger G, Voelkel AF (1992) Almitrine mimics hypoxic vasoconstriction in isolated rat lungs. Am J Physiol 263: 383–391
Payen D, Gatecel C, Plaisance P (1993) Almitrine effect on nitric oxide inhalation in adult respiratory distress syndrome. Lancet 341: 1664 (Letter)
Wysocki M, Delclaux C, Roupie E, et al (1994) Additive effect on gas exchange of inhaled nitric oxide and intravenous almitrine bismesylate in the adult respiratory distress syndrome. Intensive Care Med 20: 254–259
Roche S, Lu Q, Law-Koune JD, et al (1994) Effects of combining inhaled NO and intravenous almitrine in patients with ARDS. Anesthesiology 81:A264 (Abst)
Malassine P, Lu Q, Law-Koune JD, et al (1995) Bismesylate d’almitrine: Courbes dosereponse. Ann Fr Anesth 15: R102 (Abst)
Bromet N, Singlas E (1984) Pharmacocinetique clinique du bismesylate d’almitrine. Pre sse Medicale 13: 2071–2077
Aubert Y, Baune A, Courbe S, Guillaudeux J, Bromet N (1982) Pharmacocinetique du bismesylate d’almitrine chez l’homme. Bull Physiop Respir 18 (Suppl 4): 307–314
Tweeny J, Evans TW, Waterhouse JC, Nicoll J, Suggett AJ, Howard P (1985) Long term oxygen therapy and almitrine bismesylate. In: Allegra L, Rizzato G (ed) Bronchitis and emphysema. pp A171
Stradling JR, Barnes P, Pride NB (1982) The effects of almitrine on the ventilator response to hypoxia and hypercapnia in normal subjects. Clin Sci 63: 401–404
Wouters EFM, Greve LH, Steenhuis ES, Gimeno F (1988) Almitrine and peripheral neuropathy. Lancet 2: 336
McLeed CM, Thomas RW, Bartley EA, Parkhurst GW, Bachaud RT (1983) Effect of handling of almitrine bismesylate in healthy subjects. Eur J Respir Dis 64: 275–289
Bouche P, Lacomblez L, Leger JM, et al (1989) Peripheral neuropathies during treatment with almitrine: Report of 46 cases. J Neurol 236: 29–33
Bassenge E, Munzel T (1988) Consideration of conduit and resistance vessels in regulation of blood flow. Am J Cardiol 62: 40E-44E
Kuo L, Davis MJ, Chilian WM (1990) Endothelium-dependent, flow-induced dilation of isolated coronary arterioles. Am J Physiol 259 (Heart Circ Physiol 28):H1063-H1070
Smiesko V, Lang DJ, Johnson PC (1989) Dilator response of rat mesenteric arcading arterioles to increased blood flow velocity. Am J Physiol 257 (Heart Circ Physiol 26): H1958-H1965
Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC (1990) Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 259 (Heart Circ Physiol 28): H1038-H1043
Ristimaki A, Garfinkel S, Wessendorf J, Maciag T, Hla T (1994) Induction of cyclooxygenase-2 by interleukin-1 alpha. J Biol Chem 269: 11769–11775
Fu J, Masferrer JL, Seibert K, Raz A, Needleman P (1990) The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 265: 16737–16740
Maier JAM, Hla T, Maciag T (1990) Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J Biol Chem 265: 10805–10808
Pritchard KA, O’Banion MK, Miano JM, et al (1994) Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo. J Biol Chem 269: 8504–8509
Liu S, Crawley DE, Barnes PJ, Evans TW (1991) Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am Rev Respir Dis 143: 32–37
Leeman M, de Beyl VZ, Delcroix M, Naeije R (1994) Effects of endogenous nitric oxide on pulmonary vascular tone in intact dogs. Am J Physiol 266 (Heart Circ Physiol 35): H2343-H2347
Sprague RS, Thiemermann C, Vane JR (1992) Endogenous endothelium-derived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anesthetized rabbits. Proc Natl Acad Sci 89: 8711–8715
Putensen C, Rasanen J, Downs JB (1994) Effect of endogenous and inhaled nitric oxide on the ventilation-perfusion relationships in oleic-acid lung injury. Am J Respir Crit Care Med 150: 330–336
Lorente JA, Landin L, de Pablo R, Renes E, Liste D (1993) L-arginine pathway in the sepsis syndrome. Crit Care Med 21: 1287–1295
Brimioulle S, Lejeune P, Vachiery JL, et al (1994) Stimulus-response curve of hypoxic pulmonary vasoconstriction in intact dogs: Effects of ASA. Am J Physiol 77: 476–480
Leeman M, Lejeune P, Hallemans R, Melot C, Naeije R (1988) Effects of increased pulmonary vascular tone on gas exchange in canine oleic acid pulmonary edema. J Appl Physiol 65: 662–668
Leeman M, Delcroix M, Vachiery JL, Melot C, Naeije R (1992) Blunted hypoxic vasoconstriction in oleic acid lung injury: Effect of cyclooxygenase inhibitors. J Appl Physiol 72: 251–258
Schulman LL, Lennon PF, Ratner SJ, Enson Y (1988) Meclofenamate enhances blood oxygenation in acute oleic acid lung injury. J Appl Physiol 64: 710–718
Hales CA, Peterson M, Kong D, Miller M, Watkins WD (1981) Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs. J Clin Invest 68: 497–505
Graham LM, Vasil A, Vasil ML, Voelkel NF, Stenmark KR (1990) Decreased pulmonary vasoreactivity in an animal model of chronic pseudomonas pneumonia. Am Rev Respir Dis 142: 221–229
Schuster DP, Sandiford P, Stephenson AH (1993) Thromboxane receptor stimulation: Inhibition and perfusion redistribution after acute lung injury. J Appl Physiol 75: 2069–2078
Janssens SP, Musto SW, Hutchinson WG, et al (1994) Cyclooxygenase and lipoxygenase inhibition by BW-755C reduces acrolein smoke-induced acute lung injury. J Appl Physiol 77: 888–895
Hanly PJ, Roberts D, Dobson K, Light RB (1987) Effect of indomethacin on arterial oxygenation in critically ill patients with severe bacterial pneumonia. Lancet 1: 351–354
Steinberg SM, Rodriguez JL, Bitzer LG, Kelley KA, Flint LM (1990) Indomethacin treatment of human adult respiratory distress syndrome. Circ Shock 30: 375–384
Gattinoni L, Pesenti A, Bombino M, et al (1988) Relationships between lung computer tomographic density, gaz exchange, and PEEP in acute respiratory failure. Anesthesiology 69: 824–832
Greene R, Zapol WM, Snider MT, et al (1981) Early bedside detection of pulmonary vascular occlusion during acute respiratory failure. Am Rev Respir Dis 124: 593–601
Rouby JJ, Lherm T, Martin de Lassale E, et al (1993) Histologic aspects of pulmonary barotrauma in critically ill patients with acute respiratory failure. Intensive Care Med 20: 187–192
Dreyfuss D, Soler P, Basset G, Saumon G (1988) High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive endexpiratory pressure. Am Rev Respir Dis 137: 1159–1164
Hickling KG, Henderson SJ, Jackson R (1990) Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med 16: 372–377
Offner B, Czachurski J, Konig SA, Seller H (1994) Different effects of respiratory and metabolic acidosis on preganglionic sympathetic nerve activity. J Appl Physiol 77: 173–178
Viles PH, Shepherd JT (1968) Relationship between pH, PO2, and PCO2 on the pulmonary vascular bed of the cat. Am J Physiol 215: 1170–1176
Viles PH, Shepherd JT (1968) Evidence for a dilator action of carbon dioxide on the pulmonary vessels of the cat. Circ Res 22: 325–332
Brimioulle S, Vachiery JL, Lejeune P, Leeman M, Melot C, Naeije R (1991) Acid-base status affects gas exchange in canine oleic acid pulmonary edema. Am J Physiol 260 (Heart Circ Physiol 29): H1080-H1086
Ramieri VM, Mascia LM, Fiore T, Bruno F, Brienza A, Giuliani R (1995) Cardiorespiratory effects of positive end-expiratory pressure during progressive tidal volume reduction (permissive hypercapnia) in patients with acute respiratory distress syndrome. Anesthesiology 83: 710–720
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Puybasset, L., Rouby, J.J. (1996). Pharmacologic Approach of Hypoxemia in ARDS Patients. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine, vol 1996. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80053-5_38
Download citation
DOI: https://doi.org/10.1007/978-3-642-80053-5_38
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-60552-2
Online ISBN: 978-3-642-80053-5
eBook Packages: Springer Book Archive